Hong-Jun Lin
Overview
Explore the profile of Hong-Jun Lin including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
24
Citations
183
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lv T, Lin H, Hu H, Li F
Curr Probl Surg
. 2024 Aug;
61(8):101500.
PMID: 39098342
No abstract available.
2.
Li M, Xu Y, Lu W, Li Y, Tan S, Lin H, et al.
Oncol Lett
. 2024 Apr;
27(6):270.
PMID: 38686355
[This corrects the article DOI: 10.3892/ol.2017.7635.].
3.
Gao J, Zhu X, Wang M, Lin X, Zhuang Y, Lin H
Zhongguo Shi Yan Xue Ye Xue Za Zhi
. 2024 Feb;
32(1):219-224.
PMID: 38387925
Objective: To investigate possible mechanism on protien LMP1 expressed by EBV inducing plasmablast differentiation of DLBCL cell via the mTORC1 pathway. Methods: The expression levels of LMP1 protein, CD38 and...
4.
Dong W, Sun H, Zhang Y, Lin H, Chen J, Hong H
Chemosphere
. 2018 Aug;
211:648-652.
PMID: 30098560
Low concentrations of arsenic (As) contamination in aquatic environment is a worldwide issue, which is of great concern. To evaluate the impact of low concentrations of As on zebrafish, we...
5.
Zhang J, Guo J, Zhang T, Lin H, Qi N, Li Z, et al.
Molecules
. 2018 May;
23(6).
PMID: 29843370
We designed a series of novel phenothiazine-1,2,3-triazole hybrids by the molecular hybridization strategy and evaluated their antiproliferative activity against three cancer cell lines (MDA-MB-231, MDA-MB-468 and MCF-7). For the structure-activity...
6.
Li M, Xu Y, Lu W, Li Y, Tan S, Lin H, et al.
Oncol Lett
. 2018 Feb;
15(3):2839-2846.
PMID: 29435010
Sunitinib based adjuvant chemotherapy combined with chloroquine (CQ) for the treatment of renal cell carcinoma (RCC) is in clinical trials; however, its anti-RCC effect and the mechanism remain unclear. In...
7.
Zhang J, Guo J, Lin H, Zhang T, Li Z, Zhou J, et al.
Chin J Nat Med
. 2017 Nov;
15(10):758-765.
PMID: 29103461
Stroke remains the third leading cause of death and of adult disability worldwide. Vascular occlusion, followed by ischemic cascade, leads to irreversible tissue injury. Recombinant tissue plasminogen activator is the...
8.
Ning T, Jiang M, Peng Q, Yan X, Lu Z, Peng Y, et al.
Thorac Cancer
. 2017 Sep;
3(3):229-238.
PMID: 28920305
Introduction: To some extent endostatin normalizes tumor vasculature. However, the optimum time window and optimum drug dose for tumor vascular normalization need to be explored. Here we investigate the effect...
9.
Chen Y, Luo Y, Huang W, Hu D, Zheng R, Cong S, et al.
Comput Biol Med
. 2017 Aug;
89:18-23.
PMID: 28779596
Hepatic fibrosis is a common middle stage of the pathological processes of chronic liver diseases. Clinical intervention during the early stages of hepatic fibrosis can slow the development of liver...
10.
Zhang Y, Xu T, Gong H, Li C, Ye X, Lin H, et al.
Medicine (Baltimore)
. 2016 Nov;
95(45):e5329.
PMID: 27828854
High-resolution ultrasound (HRUS) is a sensitive tool for identifying thyroid nodules. Real-time elastography (RTE) and contrast-enhanced ultrasound (CEUS) are newly developed methods which could measure tissue elasticity and perfusion features....